Erythromycin and other macrolide antibiotics for treating Rhodococcus equi pneumonia in foals

Compendium on Continuing Education for the Practicing Veterinarian

Volumn 24, Issue 3, 2002, Pages 256-261

  Lakritz, Jeffrey ^a   Wilson, W D ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; EQUIDAE; RHODOCOCCUS EQUI;

EID: 0036341576     PISSN: 01931903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Report of the foal pneumonia panel
2. Control and prevention of Rhodococcus equi pneumonia in foals
3. Clinical manifestations, diagnosis, treatment and prevention of Rhodococcus equi infections in foals
4. The effects of combinations of selected antibiotics on the growth of Corynebacterium equi
5. Associations between physical examination, laboratory, and radiographic findings and outcome and subsequent racing performance of foals with Rhodococcus equi infection: 115 cases (1984-1992)
6. Lack of residual lung damage in horses in which Rhodococcus equi-induced pneumonia had been diagnosed
7. The influence of foal pneumonia on future racing performance
8. Risk of adverse effects in pneumonic foals treated with erythromycin versus other antibiotics: 143 cases (1986-1996)
9. Bronchointerstitial pneumonia and respiratory distress in young horses: Clinical, clinicopathologic, radiographic, and pathologic findings in 23 cases (1984-1989)
10. Effect of treatment with erythromycin on bronchoalveolar lavage fluid cell populations in foals
11. Comparison of microbiologic and high-performance liquid chromatography assays to determine plasma concentrations, pharmacokinetics, and bioavailability of erythromycin base in plasma of foals after intravenous or intragastric administration
12. Effects of prior feeding on pharmacokinetics and estimated bioavailability after oral administration of a single dose of microencapsulated erythromycin base in healthy foals
13. Pharmacokinetics of erythromycin estolate and erythromycin phosphate after intragastric administration to fasted foals
14. Pharmacokinetics of erythromycin in foals and adult horses
15. Pharmacokinetics of erythromycin ethylsuccinate after intragastric administration to healthy foals
16. Comparison of oral erythromycin formulations in the horse using pharmacokinetic profiles
17. Pharmacokinetics of azithromycin and concentration in body fluids and bronchoalveolar cells in foals
18. New treatments and management of Rhodococcus equi pneumonia in foals